A panel of dementia experts has called for further investigation into a potential link between Alzheimer's disease and viruses such as herpes and the chlamydia bacteria.
In an editorial for the Journal of Alzheimer's Disease, 31 leading scientists and doctors accused the scientific establishment of overlooking evidence that dementia is linked to microbes in the brain.
Microbes from the herpes virus, which causes cold sores, and chlamydia bacteria are found at higher rates in the brains of Alzheimer's sufferers, they claim.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Citing past cases where viral and bacterial microbes have caused dementia-like symptoms, the editorial argues that pathogens from infectious diseases could lie dormant in the brain for years before triggering the onset of Alzheimer's.
"These agents can undergo reactivation in the brain during ageing, as the immune system declines, and during different types of stress," the panel wrote.
Focusing more attention on the possibility of microbes as the answer to the Alzheimer's riddle could open up new treatments and bring science closer to a cure, they argue.
"There is incontrovertible evidence that Alzheimer's disease has a dormant microbial component," Professor Douglas Kell, one of the co-signatories, told the Daily Telegraph. "We can't keep ignoring all of the evidence."
The controversial editorial contradicts the mainstream view that dementia is linked to the build-up of proteins in the brain preventing neurons from communicating.
Professor John Hardy, an expert in neurological disease at University College London, stressed there is currently no convincing proof that infections cause Alzheimer's disease and told The Times the editorial "does not reflect what most researchers think".
Dr James Pickett, the head of research at the Alzheimer's Society, acknowledged that "there do appear to be more [microbes] in the brains of people who have died with Alzheimer's disease". However, he cautioned against making an explicit link without further research and assured the Telegraph that there is "no convincing evidence" that Alzheimer's disease is contagious.
-
Israeli double strike on Gaza hospital kills 20Speed Read The dead include five journalists who worked for The Associated Press, Reuters and Al Jazeera
-
Trump expands National Guard role in policingSpeed Read The president wants the Guard to take on a larger role in domestic law enforcement
-
Trump says he's firing Federal Reserve Governor Lisa CookSpeed Read The move is likely part of Trump's push to get the central bank to cut interest rates
-
'Wonder drug': the potential health benefits of creatineThe Explainer Popular fitness supplement shows promise in easing symptoms of everything from depression to menopause and could even help prevent Alzheimer's
-
China's soaring dementia ratesUnder The Radar Government launches action plan after cases in China increase 50% faster than global average
-
Five medical breakthroughs of 2024The Explainer The year's new discoveries for health conditions that affect millions
-
Can dementia be defeated?Today's Big Question A new report identifies 14 risk factors
-
Gene variant shows promise slowing Alzheimer'sSpeed Read A rare genetic trait called Christchurch could delay the onset of disease
-
The witchcraft myths haunting Africa's dementia patientsUnder the Radar Lack of awareness of symptoms and shortage of specialists means sufferers are vulnerable to accusations and attacks
-
How the transmission of Alzheimer's might be possibleThe Explainer New research links dementia cases to injections of human growth hormone from deceased donors' brains
-
The latest breakthroughs for Alzheimer's and dementiaIn Depth Amyloid-fighting medications, a 'revolutionary jab', blood testing and first oral drug see treatment at an inflection point, says expert
